Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors

The mammalian target of rapamycin (mTOR) regulates cell growth by integrating nutrient and growth factor signaling and is strongly implicated in cancer. But mTOR is not an oncogene, and which tumors will be resistant or sensitive to new ATP-competitive mTOR inhibitors now in clinical trials remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Ducker, Gregory S., Atreya, Chloe E., Simko, Jeffry P., Hom, Yun K., Matli, Mary R., Benes, Cyril H., Hann, Byron, Nakakura, Eric K., Bergsland, Emily K., Donner, David B., Settleman, Jeffrey, Shokat, Kevan M., Warren, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982880/
https://www.ncbi.nlm.nih.gov/pubmed/23542178
http://dx.doi.org/10.1038/onc.2013.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982880/
https://www.ncbi.nlm.nih.gov/pubmed/23542178
http://dx.doi.org/10.1038/onc.2013.92

Ejemplares similares